An AI-assisted tool for efficient prostate cancer diagnosis in low-grade and low-volume cases

被引:3
|
作者
Oner, Mustafa Umit [1 ,2 ,3 ]
Ng, Mei Ying [1 ]
Giron, Danilo Medina [4 ]
Xi, Cecilia Ee Chen [1 ]
Xiang, Louis Ang Yuan [1 ]
Singh, Malay [1 ]
Yu, Weimiao [1 ,5 ]
Sung, Wing-Kin [2 ,6 ]
Wong, Chin Fong [4 ]
Lee, Hwee Kuan [1 ,2 ,7 ,8 ,9 ,10 ]
机构
[1] ASTAR, Bioinformat Inst, Singapore 138671, Singapore
[2] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore
[3] Bahcesehir Univ, Dept Artificial Intelligence Engn, TR-34353 Istanbul, Turkey
[4] Tan Tock Seng Hosp, Dept Pathol, Singapore 308433, Singapore
[5] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore
[6] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore
[7] Singapore Eye Res Inst SERI, Singapore 169856, Singapore
[8] Image & Pervas Access Lab IPAL, Singapore 138632, Singapore
[9] Rehabil Res Inst Singapore, Singapore 308232, Singapore
[10] Singapore Inst Clin Sci, Singapore 117609, Singapore
来源
PATTERNS | 2022年 / 3卷 / 12期
关键词
WHOLE-SLIDE IMAGES; ARTIFICIAL-INTELLIGENCE; BIOPSIES;
D O I
10.1016/j.patter.2022.100642
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Pathologists diagnose prostate cancer by core needle biopsy. In low-grade and low-volume cases, they look for a few malignant glands out of hundreds within a core. They may miss a few malignant glands, resulting in repeat biopsies or missed therapeutic opportunities. This study developed a multi-resolution deep- learning pipeline to assist pathologists in detecting malignant glands in core needle biopsies of low-grade and lowvolume cases. Analyzing a gland at multiple resolutions, our model exploited morphology and neighborhood information, which were crucial in prostate gland classification. We developed and tested our pipeline on the slides of a local cohort of 99 patients in Singapore. Besides, we made the images publicly available, becoming the first digital histopathology dataset of patients of Asian ancestry with prostatic carcinoma. Our multi-resolution classification model achieved an area under the receiver operating characteristic curve (AUROC) value of 0.992 (95% confidence interval [CI]: 0.985-0.997) in the external validation study, showing the generalizability of our multi-resolution approach.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Can prostate needle biopsies predict low-volume and insignificant prostate cancer?
    Berg, K. D.
    Roder, M. A.
    Brasso, K.
    Vainer, B.
    Iversen, P.
    APMIS, 2012, 120 : 8 - 8
  • [22] Low-grade toxicity after conformal radiation therapy for prostate cancer - Impact of bladder volume
    Pinkawa, M
    Fischedick, K
    Asadpour, B
    Gagel, B
    Piroth, MD
    Eble, MJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (03): : 835 - 841
  • [23] Low-Grade Prostate Cancer: Time to Stop Calling It Cancer comment
    Eggener, Scott E.
    Berlin, Alejandro
    Vickers, Andrew J.
    Paner, Gladell P.
    Wolinsky, Howard
    Cooperberg, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (27) : 3110 - +
  • [24] Low-grade prostate cancer should still be labelled cancer Comment
    Iczkowski, Kenneth A.
    Molina, Mariel
    Egevad, Lars
    Bostwick, David G.
    van Leenders, Geert J. L. H.
    La Rosa, Francisco G.
    van der Kwast, Theodorus
    Berney, Daniel M.
    Evans, Andrew J.
    Wheeler, Thomas M.
    Leite, Katia R. M.
    Samaratunga, Hemamali
    Srigley, John
    Varma, Murali
    Tsuzuki, Toyonori
    Lucia, Marshall Scott
    Crawford, Elward David
    Harris, Richard G.
    Stricker, Philip
    Lawrentschuk, Nathan
    Woo, Henry H.
    Fleshner, Neil E.
    Shore, Neal D.
    Yaxley, John
    Bratt, Ola
    Wiklund, Peter
    Roberts, Matthew
    Cheng, Liang
    Delahunt, Brett
    BJU INTERNATIONAL, 2022, 130 (06) : 741 - 743
  • [25] Active surveillance in Canadian men with low-grade prostate cancer
    Cristea, Octav
    Lavallee, Luke T.
    Montroy, Joshua
    Stokl, Andrew
    Cnossen, Sonya
    Mallick, Ranjeeta
    Fergusson, Dean
    Momoli, Franco
    Cagiannos, Illias
    Morash, Christopher
    Breau, Rodney H.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (08) : E141 - E147
  • [26] Immunohistochemistry as a fundamental tool for the differential diagnosis of polymorphous low-grade adenocarcinoma
    de Vasconcellos, Luana Marotta Reis
    Silveiral, Vanessa Avila Sarmento
    Rosa, Luiz Eduardo Blumer
    Cavalvante, Ana Sueli Rodrigues
    Carvalho, Yasmin Rodarte
    QUINTESSENCE INTERNATIONAL, 2006, 37 (07): : 565 - 573
  • [27] Pharmacokinetic MRI of the Prostate: Parameters for Differentiating Low-Grade and High-Grade Prostate Cancer
    Franiel, T.
    Luedemann, L.
    Taupitz, M.
    Rost, J.
    Asbach, P.
    Beyersdorff, D.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2009, 181 (06): : 536 - 542
  • [28] Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis
    Bjorklund, Johan
    Cheung, Douglas C. C.
    Martin, Lisa J. J.
    Komisarenko, Maria
    Lajkosz, Katharine
    Hamilton, Robert J. J.
    Zlotta, Alexandre R. R.
    Finelli, Antonio
    SCANDINAVIAN JOURNAL OF UROLOGY, 2023, 57 (1-6) : 29 - 35
  • [29] The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer
    Berlin, Alejandro
    Ramotar, Matthew
    Santiago, Anna T.
    Liu, Zhihui
    Li, Joyce
    Wolinsky, Howard
    Wallis, Christopher J. D.
    Chua, Melvin L. K.
    Paner, Gladell P.
    van der Kwast, Theodorus
    Cooperberg, Matthew R.
    Vickers, Andrew J.
    Urbach, David R.
    Eggener, Scott E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11): : 1364 - 1373
  • [30] REEVALUATION OF THE NEED FOR PELVIC LYMPHADENECTOMY IN LOW-GRADE PROSTATE-CANCER
    FOURNIER, GR
    NARAYAN, P
    BRITISH JOURNAL OF UROLOGY, 1993, 72 (04): : 484 - 488